Inflazome
Dublin
About Inflazome
Inflazome is a biotech company that develops orally available drugs to address inflammatory diseases by targeting inflammasomes. The company's drugs block inflammasome signals, eliminating a root cause of inflammation, enabling healthcare institutions to avail targeted therapies for inflammatory diseases such as Parkinson's, Alzheimer's, atherosclerosis, and type 2 diabetes. The company was incorporated in 2016 and is headquartered in Dublin, Ireland.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $63.8M
- Funding stage: M&A
- Last round: Grant (Mar 2019)
- Website: inflazome.com#introduction
- Phone: +35316798591
Industries & Categories
Biopharma, Biotechnology, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/inflazome-131654 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.